| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Cytoplasmic transfer in oocytes: biochemical aspects Levy R; Elder K; Menezo YHum Reprod Update  2004[May]; 10 (3): 241-50Cytoplasmic control of preimplantation development is not a 'new' concept; the  first cytoplasmic transfer experiment was performed in the mouse during the early  1980s, as a means of overcoming cleavage arrest at the 2-cell stage, the '2-cell  block'. Since the first human pregnancy following the transfer of cytoplasm from  donor oocytes into the oocytes of a patient with a history of poor embryo  development and recurrent implantation failure in 1997, >30 children have been  born after direct injection of ooplasm from fresh, mature or immature, or  cryopreserved-thawed donor oocytes into recipient oocytes via a modified ICSI  technique. Transfer of ooplasm was thus applied with astonishing speed in humans,  in the absence of extensive research to evaluate the efficacy and the possible  risks of the method. This review focuses on biochemical mechanisms by which  transfer of ooplasm might confer a benefit: by correcting a putative imbalance  between anti- and pro-apoptotic factors and/or correction of defective  mitochondrial membrane potential. We also emphasize the 'empirical' state of this  technique, and the related risks.|Animals[MESH]|Blastocyst[MESH]|Cytoplasm/chemistry/*physiology[MESH]|Fertilization in Vitro/*methods/*standards[MESH]|Humans[MESH]|Oocytes/*physiology[MESH]
 |